Cunning Capital Partners LP Sells 4,695 Shares of HCA Healthcare, Inc. $HCA

Cunning Capital Partners LP decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 44.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,775 shares of the company’s stock after selling 4,695 shares during the period. HCA Healthcare makes up about 1.2% of Cunning Capital Partners LP’s holdings, making the stock its 25th largest holding. Cunning Capital Partners LP’s holdings in HCA Healthcare were worth $2,696,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in HCA. Palisade Asset Management LLC purchased a new stake in HCA Healthcare during the third quarter valued at about $26,000. Holos Integrated Wealth LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at about $29,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at about $31,000. JPL Wealth Management LLC purchased a new stake in HCA Healthcare during the third quarter valued at about $33,000. Finally, Aventura Private Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Michael Burry reportedly loaded up on HCA shares, saying the recent selloff created a buying opportunity and highlighting HCA’s strong compounding potential. Michael Burry Loads Up On HCA, Says Selloff Created A Buying Opportunity — ‘Insanely Efficient Compounder’
• Positive Sentiment: HCA announced an agreement to acquire The College of Health Care Professions, a move that could strengthen its healthcare workforce pipeline and expand its training footprint. HCA Healthcare (HCA) Announces Agreement to Acquire The College of Health Care Professions
• Positive Sentiment: HCA’s ongoing urgent care expansion, including securing additional Lowcountry clinic locations, points to continued outpatient growth and broader patient access. HCA’s urgent care spree continues
• Neutral Sentiment: HCA Surgery Ventures named a supply chain CEO, an operational move that may improve execution but is unlikely to be a major short-term stock driver. HCA Surgery Ventures names supply chain CEO
• Neutral Sentiment: HCA also awarded a grant to a STEM program and was highlighted in community/hospital staffing stories, which are supportive of its brand but likely have limited direct impact on earnings. HCA Healthcare awards grant to STEM program

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $374.01 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The company has a market cap of $82.97 billion, a PE ratio of 12.86, a P/E/G ratio of 1.15 and a beta of 1.12. The stock’s 50-day moving average is $435.15 and its 200 day moving average is $475.62.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

Analyst Ratings Changes

Several research firms have recently commented on HCA. Jefferies Financial Group reiterated a “buy” rating and issued a $525.00 price objective on shares of HCA Healthcare in a report on Friday, April 24th. Leerink Partners decreased their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft decreased their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Argus decreased their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.